The levels of the maternal serum markers alpha-fetoprotein (AFP), human chorionic gonadotrophin (hCG), and unconjugated oestriol (uE,) in 35 pregnant women with early second-trimester oligohydramnios differed from those in a reference population of 1699 singleton pregnancies. Maternal serum AFP levels above the 95th centile of the population distribution were observed in 80 per cent (16120) KEY woms-Second-trimester oligohydramnios, alpha-fetoprotein, human chorionic gonadotrophin, unconjugated oestriol, maternal serum.
INTRODUCTION
The simultaneous measurement of maternal serum alpha-fetoprotein (AFP), human chorionic gonadotrophin (hCG), and unconjugated oestriol (uE3) concentrations is used for second-trimester screening for fetal Down's syndrome Haddow et al., 1992; Cheng et al., 1993) . Apart from fetal chromosomal abnormalities, adverse pregnancy outcome and various complications of pregnancy are associated with abnormal concentrations of these serum markers (Beekhuis et al., 1992; Cuckle et al., 1992) . In early secondtrimester oligohydramnios, usually raised maternal serum AFP levels are encountered (Dyer et al., 1987; Richards et al., 1988 rise of the maternal serum AFP levels in this condition has been shown to be of amniotic fluid origin (Los et al., 1992) . Since placental insuf€i-ciency has been established in a significant number of oligohydramnios patients (Hackett et al., 1987) , we subjected stored serum samples of oligohydramnios patients to additional measurement of hCG and uE3, originating from the placenta and the feto-placental unit, respectively (Hay, 1988; Canick et al., 1988) , in order to study the profile of the placental markers in oligohydramnios. The scores of the three markers were introduced in the software package 'alpha' for risk estimates for fetal Down's syndrome and neural tube defects.
MATERIAL AND METHODS
Thirty-nine patients with second-trimester oligohydramnios between 15 and 20 weeks of gestational age were detected in a 4-year period among 5000 pregnant women referred to us for ultrasound evaluation. In 35 of them, it was possible to obtain a serum sample with informed consent. The serum samples were stored at -80°C until assay and underwent only two thawinglfreezing procedures for this investigation. The technique of ultrasound investigation has been described in detail before (Los et al., 1992). The diagnosis of oligohydramnios was established when the largest and nearly always the only pocket of amniotic fluid measured up to 2 cm (Chamberlain et a/., 1984) . The reference population consisted of 1699 women with singleton pregnancies and ultrasonographically determined gestational ages between 15 and 20 weeks. From various hospitals the serum samples of these women had been submitted for measurement of AFP, hCG, and uE, concentrations, without a thawinglfreezing procedure. AFP, hCG, and uE, were assayed with the Amerlex M second-trimester radioimmunoassay (RIA) kits for AFP, hCG, and free oestriol (Amersham). All concentrations were expressed as multiples of the median values (MOM) of the reference population for the respective week of gestation.
Risk calculations for fetal Down's syndrome and fetal neural tube defects were performed with the software package 'alpha', based on maternal age and the trivariate Gaussian distribution of log AFP, log hCG, and linear uE, concentrations . Cut-off points for a positive test were taken as a risk of 1:250 or higher for fetal Down's syndrome and an AFP level at or exceeding 2.5 MOM.
Statistical analysis allowed for the use of parametric tests since the serum marker levels have been shown to fit (log) Gaussian distributions (Cuckle et al., 1987; Wald et al., 1988; Crossley et al., 1993) .
RESULTS
The oligohydramnios cases consisted of 35 patients (the group oligo f ); 15 displayed associated fetal malformations on ultrasound investigation (the group oligo+), whereas 20 patients had no fetal malformations except intrauterine growth retardation in six cases (the group oligo -; Table   I ). Autopsy of the fetus confirmed the previous ultrasound diagnosis in 31 cases; in two cases no autopsy was available, and in the remaining two cases a live infant was born. The levels of AFP, hCG, and uE, in the groups oligo+ and oligoare presented in Fig. 1 and Table 11 . The median AFP level in both oligohydramnios groups was raised, compared with that in the reference popu- 
DISCUSSION
Raised maternal serum AFP levels in secondtrimester oligohydramnios are mainly associated with the presence of a normal fetus, and originate from the diminished amniotic fluid compartment (Los et af., 1992). In the 15 cases of oligohydramnios with associated fetal malformations, a renal or a post-renal fetal anuridoliguria was present. An increased AFP transfer from the amniotic fluid compartment towards the maternal compartment, modulated by the presence or absence of fetal diuresis, explains the distinct distributions of AFP levels in-between the groups oligo+ and oligo -, and between these groups and the reference population.
The concentrations of hCG show a higher median level and a wider distribution of values in the oligohydramnios patients than in the reference population, resulting in an increased number of elevated levels, known to be associated with placental pathology (Bogart et al., 1987; Hay, 1988; Beekhuis et al., 1992) . The uE3 distribution in oligohydramnios shows a normal median level but a wider distribution of values than that in the reference population resulting in a significant number of decreased levels. Decreased uE3 levels are, at least in the third trimester of pregnancy, associated with reduced placental function (Chard et af., 1985; Perry et al., 1986). Early second-trimester oligohydramnios represents a serious complication of pregnancy associated with an abnormal profile of the serum markers AFP, hCG, and uE3, resulting in a signscant increased percentage (57 per cent) of screenpositive cases for fetal neural tube defects and/or Down's syndrome.
